Trial Profile
A multicentre dose escalation study of irinotecan and carboplatin in chemotherapy naive patients with extensive small cell lung cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Aug 2005
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Irinotecan (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 02 Aug 2005 New trial record.